JP2017532289A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017532289A5 JP2017532289A5 JP2017500952A JP2017500952A JP2017532289A5 JP 2017532289 A5 JP2017532289 A5 JP 2017532289A5 JP 2017500952 A JP2017500952 A JP 2017500952A JP 2017500952 A JP2017500952 A JP 2017500952A JP 2017532289 A5 JP2017532289 A5 JP 2017532289A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- amino acid
- proline
- tryptophan
- phenylalanine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462021308P | 2014-07-07 | 2014-07-07 | |
| US62/021,308 | 2014-07-07 | ||
| PCT/EP2015/065362 WO2016005328A2 (en) | 2014-07-07 | 2015-07-06 | IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID ß (Aß) AMINO ACID SEQUENCES AND USES THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020156999A Division JP2021001203A (ja) | 2014-07-07 | 2020-09-18 | 突然変異タンパク質アミロイドβ（Ａβ）アミノ酸配列に基づく免疫原性産物およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017532289A JP2017532289A (ja) | 2017-11-02 |
| JP2017532289A5 true JP2017532289A5 (enExample) | 2018-08-16 |
Family
ID=53525183
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017500952A Pending JP2017532289A (ja) | 2014-07-07 | 2015-07-06 | 突然変異タンパク質アミロイドβ（Ａβ）アミノ酸配列に基づく免疫原性産物およびその使用 |
| JP2020156999A Pending JP2021001203A (ja) | 2014-07-07 | 2020-09-18 | 突然変異タンパク質アミロイドβ（Ａβ）アミノ酸配列に基づく免疫原性産物およびその使用 |
| JP2022192713A Pending JP2023036606A (ja) | 2014-07-07 | 2022-12-01 | 突然変異タンパク質アミロイドβ（Ａβ）アミノ酸配列に基づく免疫原性産物およびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020156999A Pending JP2021001203A (ja) | 2014-07-07 | 2020-09-18 | 突然変異タンパク質アミロイドβ（Ａβ）アミノ酸配列に基づく免疫原性産物およびその使用 |
| JP2022192713A Pending JP2023036606A (ja) | 2014-07-07 | 2022-12-01 | 突然変異タンパク質アミロイドβ（Ａβ）アミノ酸配列に基づく免疫原性産物およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20160000891A1 (enExample) |
| EP (1) | EP3166969A2 (enExample) |
| JP (3) | JP2017532289A (enExample) |
| CN (1) | CN107074924A (enExample) |
| AU (2) | AU2015286824A1 (enExample) |
| CA (1) | CA2954031A1 (enExample) |
| IL (1) | IL249925B (enExample) |
| MX (1) | MX2017000094A (enExample) |
| RU (1) | RU2750268C2 (enExample) |
| SG (1) | SG11201700071WA (enExample) |
| WO (1) | WO2016005328A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20180058863A (ko) | 2005-11-30 | 2018-06-01 | 애브비 인코포레이티드 | 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도 |
| MX336196B (es) * | 2010-04-15 | 2016-01-11 | Abbvie Inc | Proteinas de union a amiloide beta. |
| EP3533803B1 (en) | 2010-08-14 | 2021-10-27 | AbbVie Inc. | Anti-amyloid-beta antibodies |
| CN107074924A (zh) * | 2014-07-07 | 2017-08-18 | 艾伯维德国有限责任两合公司 | 基于突变蛋白β淀粉样蛋白(Aβ)氨基酸序列的免疫原性产物及其用途 |
| WO2018047792A1 (ja) * | 2016-09-06 | 2018-03-15 | 富士レビオ株式会社 | サイログロブリンの測定方法及び測定試薬 |
| US11802867B2 (en) | 2016-09-13 | 2023-10-31 | Fujirebio Inc. | Cardiac troponin assay method and assay reagent |
| CN112218877B (zh) | 2018-08-27 | 2025-07-25 | 瑞泽恩制药公司 | 拉曼光谱在下游纯化中的应用 |
| CN110412294B9 (zh) * | 2019-08-07 | 2023-05-26 | 深圳市新产业生物医学工程股份有限公司 | 蛋白稳定液、蛋白校准品、试剂盒及检测蛋白校准品稳定性的方法 |
| US12352719B2 (en) | 2019-09-20 | 2025-07-08 | KYCERA AVX Components Corporation | Somatic cell-based electrical biosensor |
| CN112851786B (zh) * | 2019-11-12 | 2022-11-15 | 深圳市新产业生物医学工程股份有限公司 | 可溶性的Aβ1-42变体、Aβ1-42校准品及试剂盒 |
| CN111793131A (zh) * | 2020-05-11 | 2020-10-20 | 廊坊天光生物技术有限公司 | 一种用于检测血清中pf4含量的抗体对及其用途 |
| EP4286405A4 (en) * | 2021-01-28 | 2025-03-19 | Abrain | GENE THERAPY FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| EP4230645A1 (en) * | 2022-02-22 | 2023-08-23 | Technische Universität München | Peptidic inhibitors of amyloid self- and cross-assembly |
| CN117586370A (zh) * | 2022-08-09 | 2024-02-23 | 深圳智源生物医药有限公司 | 强毒性淀粉样蛋白寡聚体及其用途 |
| CN117700525B (zh) * | 2024-02-05 | 2024-06-18 | 上海良润生物医药科技有限公司 | 一种多肽改造体及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7964192B1 (en) * | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
| PT1954718E (pt) * | 2005-11-30 | 2014-12-16 | Abbvie Inc | Anticorpos anti-globulómeros aβ, suas porções de ligação ao antigénio, correspondentes hibridomas, ácidos nucleicos, vectores, células hospedeiras, métodos de produção dos ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos para uso dos ditos anticorpos |
| CN102203124A (zh) * | 2008-07-25 | 2011-09-28 | 雅培制药有限公司 | 淀粉状蛋白β肽类似物，其寡聚物，用于制备的方法以及包括所述类似物或寡聚物的组合物，及其用途 |
| MX336196B (es) * | 2010-04-15 | 2016-01-11 | Abbvie Inc | Proteinas de union a amiloide beta. |
| EP3533803B1 (en) * | 2010-08-14 | 2021-10-27 | AbbVie Inc. | Anti-amyloid-beta antibodies |
| CN107074924A (zh) * | 2014-07-07 | 2017-08-18 | 艾伯维德国有限责任两合公司 | 基于突变蛋白β淀粉样蛋白(Aβ)氨基酸序列的免疫原性产物及其用途 |
-
2015
- 2015-07-06 CN CN201580047718.9A patent/CN107074924A/zh active Pending
- 2015-07-06 US US14/792,500 patent/US20160000891A1/en not_active Abandoned
- 2015-07-06 EP EP15735674.2A patent/EP3166969A2/en not_active Withdrawn
- 2015-07-06 RU RU2017103527A patent/RU2750268C2/ru active
- 2015-07-06 MX MX2017000094A patent/MX2017000094A/es unknown
- 2015-07-06 CA CA2954031A patent/CA2954031A1/en active Pending
- 2015-07-06 AU AU2015286824A patent/AU2015286824A1/en not_active Abandoned
- 2015-07-06 JP JP2017500952A patent/JP2017532289A/ja active Pending
- 2015-07-06 SG SG11201700071WA patent/SG11201700071WA/en unknown
- 2015-07-06 WO PCT/EP2015/065362 patent/WO2016005328A2/en not_active Ceased
-
2017
- 2017-01-04 IL IL249925A patent/IL249925B/en unknown
-
2020
- 2020-09-18 JP JP2020156999A patent/JP2021001203A/ja active Pending
-
2021
- 2021-01-29 AU AU2021200575A patent/AU2021200575A1/en not_active Abandoned
-
2022
- 2022-10-27 US US18/050,314 patent/US20240075114A1/en active Pending
- 2022-12-01 JP JP2022192713A patent/JP2023036606A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017532289A5 (enExample) | ||
| RU2017103527A (ru) | ИММУНОГЕННЫЕ ПРОДУКТЫ, ПОЛУЧЕННЫЕ НА ОСНОВЕ АМИНОКИСЛОТНЫХ ПОСЛЕДОВАТЕЛЬНОСТЕЙ МУТЕИНОВОГО АМИЛОИДА β(Aβ), И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| So et al. | Controlling self-assembly of engineered peptides on graphite by rational mutation | |
| JP2011529084A5 (enExample) | ||
| JPH06501938A (ja) | ペプチドよりなるｈｉｖ複製阻害剤 | |
| JP2011528561A5 (enExample) | ||
| Zhang et al. | Multiple-peptide conjugates for binding β-amyloid plaques of Alzheimer's disease | |
| Yamada et al. | Ile‐Lys‐Val‐Ala‐Val (IKVAV)‐containing laminin α1 chain peptides form amyloid‐like fibrils | |
| JP2011523550A5 (enExample) | ||
| RU2010119521A (ru) | Антитела, связывающие il-4 и/или il-13, и их применение | |
| RU2013129815A (ru) | Антигенсвязывающая молекула, способная многократно связываться с множеством антигенных молекул | |
| RU2008120027A (ru) | Анти-addl моноклональное антитело и его применение | |
| JP2019502684A5 (enExample) | ||
| RU2011100125A (ru) | Соединения для лечения амилоидозов | |
| RU2015126533A (ru) | Анти-cd47 антитела и способы их применения | |
| WO2005025616A1 (ja) | 抗体の用途 | |
| FI2897981T3 (fi) | Anti-CD3-vasta-aineita, bispesifisiä antigeeniä sitovia molekyylejä, jotka sitovat CD3:a ja CD20:ta, ja niiden käyttöjä | |
| RU2012140954A (ru) | Антитела, связывающиеся с протофибриллами, и их применение в методах терапии и диагностики болезни паркинсона, деменции, ассоциированной с образованием диффузных телец леви, и других а-синуклеинопатий | |
| RU2010151725A (ru) | Аминокислотные последовательности, направленные против cхcr4 и других gpcr, и соединения, включаюшие их | |
| RU2011100126A (ru) | Применение мимотопов для лечения бетта-амилоидозов | |
| RU2013106270A (ru) | Моноклональное антитело против addl и его применения | |
| EA200970694A1 (ru) | ПЭГИЛИРОВАННЫЕ Fab-ФРАГМЕНТЫ АНТИТЕЛ К ПЕПТИДУ Aβ | |
| JP2013524774A5 (enExample) | ||
| JP2009519895A5 (enExample) | ||
| JP2016531546A5 (enExample) |